Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q4 2016 · 10-K
Revenue$135.31M$135.31M+0.6% vs Q4 2015 Net Income$4.73M$4.73M+12.7% vs Q4 2015 EPS Diluted$0.17$0.17+13.3% vs Q4 2015 Gross Profit$22,784,000+22.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$14,332,000— Free Cash Flowderived$796,000−86.6% Margins · derivedGross margin16.8%+3.0 pt vs Q4 2015
Operating margin4.6%
Net margin3.5%+0.4 pt vs Q4 2015
ended May 29, 2016 · filed Aug 1, 2016 · 64 d after period end